Champions Oncology, Inc. services
Others
Discovery Services
Champions` Discovery Services leverages the Lumin Analytic Engine and rapid validation workflows to identify novel therapeutic targets and/or biomarkers of resistance.
Driving Oncology Research Services
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the globe.
Research Services & Partnering - Clinical Trial Solutions
Clinical Flow Cytometry
Champions Oncology’s clinical flow cytometry services are implemented using fully optimized and validated human panels developed to be customizable to meet your clinical trial needs. Champions Oncology leads the industry in clinical flow cytometry expertise and innovative technology that provides you with the highest quality, complex computational results with the ability to interrogate up to 26 parameters on each individual cell simultaneously within every patient sample.
Research Services & Partnering - Preclinical Testing Platforms
Analytical Endpoint Testing
Champions Oncology’s Analytical Testing platforms can be used to gather additional data at the endpoint of a preclinical model or ex vivo assay. Using multiplex cytokine assays with flow cytometry readouts, immune cell cytokine intracellular and extracellular staining upon activation can be assessed. Champions Oncology can also collect tissues from your in vivo studies and evaluate pathological changes throughout the tissue and/or the tumor itself using Immunohistochemistry (IHC) and other plate-based platforms (i.e. Luminex/ELISA platforms).
Screen Enrollment
Champions Oncology has created screens that enroll each month in either In vivo, Ex Vivo or In vitro platforms. These screens allow for a significant cost savings compared to running stand-alone studies as well as provide free access to Standard of Care response data and other characterization data for each model. Check back frequently to learn more about each screen and to enroll in any active screens.